I think the large majority of the shareholders here are flippers… great product, but it’s an otc stock with minimal experience on expansion of a treatment of this magnitude… it will take a years and years in my opinion for this to come to fruition, if at all… A BO is more likely, and that rides on a lot of things and most likely will not come until successful human clinical trials which take awhile.